Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Debt to Equity Ratio : 0.011 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.011 |
| March 31, 2026 | 0.0149 |
| December 31, 2025 | 0.0168 |
| September 30, 2025 | 0.0167 |
| June 30, 2025 | 0.0169 |
| March 31, 2025 | 0.0165 |
| December 31, 2024 | 0.0161 |
| September 30, 2024 | 0.0205 |
| June 30, 2024 | 0.0203 |
| March 31, 2024 | 0.0008 |
| December 31, 2023 | 0.0034 |
| September 30, 2023 | 0.006 |
| June 30, 2023 | 0.0083 |
| March 31, 2023 | 0.0142 |
| December 31, 2022 | 0.017 |
| September 30, 2022 | 0.0174 |
| June 30, 2022 | 0.0179 |
| March 31, 2022 | 0.0177 |
| December 31, 2021 | 0.0195 |
| September 30, 2021 | 0.019 |
| June 30, 2021 | 0.0147 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0216 |
| December 31, 2020 | 0.0213 |
| September 30, 2020 | 0.0371 |
| June 30, 2020 | 0.0395 |
| March 31, 2020 | 0.2674 |
| December 31, 2019 | 0.2127 |
| September 30, 2019 | 0.0787 |
| June 30, 2019 | 0.0923 |
| March 31, 2019 | 0.0798 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Gilead Sciences, Inc. | 2.219 |
| Insmed, Inc. | 0.9865 |
| Madrigal Pharmaceuticals, Inc. | 0.664 |
| AbbVie, Inc. | -11.93 |
| PTC Therapeutics, Inc. | -4.212 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 885.54M |
| Total Liabilities (Quarterly) | 44.00M |
| Shareholders Equity (Quarterly) | 841.54M |
| Current Ratio | 21.71 |
| Net Debt Paydown Yield | 0.01% |